FDA updates labeling for ROMVIMZA FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for DECIPHERA PHARMS. Active ingredient: VIMSELTINIB. Decision date: 12/12/2025 Full text
There are no comments here yet...